Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a cream stop light from darkening your skin?

NCT ID NCT07537595

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested seven different cosmetic creams to see if they could prevent skin darkening caused by high-energy visible light (like from the sun or screens). 33 healthy adults with fair to medium skin had creams applied to their back before being exposed to a specific blue-violet light. Researchers measured skin color changes and checked for redness or irritation over 7 weeks to find out which products worked best.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

33 people

The number who actually took part.

Started

Jun 2024

Finished

Dec 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Healthy male and female volunteers from 18 to 60 yo, with Fitzpatrick III and IV and an ITA° between 18° to 35° at screening.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Caucasian subjects 2. Male and female participants 3. Aged between 18 and 60 years old 4. Skin phototypes III-IV 5. Average ITA° on the back between 18° and 35° (± 2°) at screening and baseline/inclusion visit 6. Uniform skin color over the eight test zones (difference in ITA° between each zone ≤ 4°) 7. Untanned back (no UV exposure - natural or artificial - during the 2 months prior to inclusion) 8. No scar, spot, tattoo or excess hair on investigational zones 9. Subject having given written informed consent 10. Subjects able to read and understand study documents 11. Subjects with an official domicile 12. Subject covered by health insurance or social security 13. Female subjects of child-bearing potential using a safe method of contraception for at least 3 months prior to and throughout the study Exclusion Criteria: 1. Pregnant, lactating, or planning to become pregnant during the study 2. Planned UV exposure (sunlight or sunbeds) of investigational zones throughout the study 3. Sunbed use or sun exposure of investigational zones within the 3 months prior to inclusion 4. Presence of sunburn (erythema) on the back 5. Dermatological disorders affecting investigational zones (naevi, freckles, excess hair, uneven skin tone, vitiligo, photodermatological problems) 6. History of skin cancer 7. History of abnormal response to sun 8. Presence of recent suntan or photo-test marks (per investigator opinion) 9. History of allergy, hypersensitivity, or serious reaction to any cosmetic product 10. Any concomitant medical condition that may interfere with the study (per investigator opinion) 11. Use of systemic medication for more than 5 consecutive days within the month prior to inclusion (e.g., steroids, antihistamines, antibiotics, vitamin A derivatives, psoralen) 12. Use of depigmenting, whitening or propigmenting topical treatments within the 3 months prior to inclusion 13. Physical treatment including laser or phototherapy (PUVA, IPL, PDT) within the past 6 months on investigational sites 14. Planned intensive sport (\> 5 hours per week) or swimming during the study 15. Participation in another clinical study within 30 days prior to inclusion 16. Deprived of liberty by adjunction or official decision 17. Unable to be contacted by phone in case of emergency

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy volunteers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CIDP Biotechnology S.R.L

    Bucharest, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.